Back

Glucagon-like peptide-1 receptor agonists reduce atrial fibrillation among patients with heart failure with preserved ejection fraction - A meta-analysis of randomised-controlled trials

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: HFpEF progress Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Rohanti Ravikulan

Flinders Medical Centre, Adelaide (Australia)

6 More presentations in this session

Presentation thumbnail
Real-world treatments and outcomes in very old patients with heart failure with preserved ejection fraction
Professor O. Hanon (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Prognostic value of the combination of marasmus and kwashiorkor in patients admitted for acute decompensated heart failure with preserved ejection fraction
Doctor R. Yagi (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Multicellular trajectories leading to subclinical diastolic dysfunction and HFpEF progression in cardiometabolic comorbidities.
Miss A. Ausiello (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
An alternative clinical score for the diagnosis of heart failure with preserved left ventricular ejection fraction in patients with atrial fibrillation
Doctor A. Sevcik (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Plasma proteomic profiles of left ventricular diastolic dysfunction differ by sex in a population at risk for cardiovascular disease
Doctor E. Dal Canto (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
HFpEF progress

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Effect of glucagon-like peptide-1 receptor agonists on atrial fibrillation incidence: a systematic review and meta-analysis
thumbnail
Congress Presentation
Sglt2 inhibitors vs. dpp-4 inhibitors and glp-1 receptor agonists on atrial fibrillation incidence in type 2 diabetes: a meta-analysis
thumbnail
Congress Presentation
Primary prevention of heart failure with glucagon-like peptide-1 receptor agonist

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources